Send the following on WhatsApp
Continue to ChatStory : Seres shares fall 55% after the company says its colitis drug failed in mid-stage clinical trial #FinanceUSA #StockMarketNEWS Shares of Seres Therapeutics Inc. tumbled 55.4% in premarket trading on https://munafa.co.com/story/1093/Seres-Shares-Fall-55-After-The-Company-Says-Its-Colitis-Drug-Failed-In-Mid-Stage-Clinical-Trial-FinanceUSA-StockMarketNEWS-Shares-Of-Seres-Therapeutics-Inc-Tumbled-55-4-In-Premarket-Trading-On/